| Size | Price | Stock | Qty |
|---|---|---|---|
| 500mg |
|
||
| Other Sizes |
| Targets |
5-Methoxyindole-3-acetic acid does not have a specific well-defined pharmacological target, as it is primarily used as a research reagent and metabolite. As a derivative of melatonin, it may interact with melatonin receptors or other targets involved in the regulation of circadian rhythms. It is also a plant auxin metabolite and is used in the analysis of auxin physiology. Its role as a metabolite makes it relevant for studying melatonin metabolism and pineal function.
|
|---|---|
| ln Vitro |
5-Methoxyindole-3-acetic acid exhibits in vitro activity as a chemical reagent and metabolite. It is used in the analysis of the physiological properties of auxins. It is also a reactant for the preparation of various compounds. Its activity is assessed in chemical and biochemical assays. These in vitro activities confirm its utility as a research tool in melatonin and auxin research.
|
| ln Vivo |
5-Methoxyindole-3-acetic acid is not typically used as a therapeutic agent in vivo. However, as a metabolite of melatonin, it may be involved in various physiological processes, including the regulation of the sleep-wake cycle. Its levels in biological fluids can be measured to assess melatonin metabolism. In toxicological studies, it may be evaluated for its effects on metabolism and excretion.
|
| Enzyme Assay |
5-Methoxyindole-3-acetic acid does not have specific enzyme/receptor binding assays associated with it, as it is not a typical drug target compound. However, its levels in biological samples can be measured using LC-MS or other analytical techniques. Its role as a metabolite can be studied using metabolomics techniques.
|
| Cell Assay |
5-Methoxyindole-3-acetic acid is not typically used in cellular assays as a pharmacological agent. However, its effects on cells can be studied in the context of melatonin metabolism. Cells may be treated with the compound, and its effects on cell function or gene expression are assessed. These assays are used in pineal and circadian rhythm research.
|
| Animal Protocol |
In vivo animal experiments with 5-Methoxyindole-3-acetic acid are primarily conducted for metabolic studies. The compound's levels in plasma, urine, and tissues are measured to assess melatonin metabolism. These studies help define the compound's role in melatonin physiology.
|
| ADME/Pharmacokinetics |
5-Methoxyindole-3-acetic acid is a small, polar molecule with a molecular weight of 205.21. It is soluble in organic solvents. Its pharmacokinetic profile is related to melatonin metabolism. The compound is typically stored at room temperature.
|
| Toxicity/Toxicokinetics |
5-Methoxyindole-3-acetic acid is considered to have low toxicity based on its use as a research compound and its occurrence as a natural metabolite. However, comprehensive toxicological evaluations have not been extensively published. The compound is intended for research use only and is not approved for human therapeutic use. Standard laboratory safety precautions should be followed when handling this compound.
|
| References | |
| Additional Infomation |
5-Methoxyindole-3-acetic acid (5-IAA) is a member of the indole-3-acetic acid class of compounds, characterized by the substitution of a methoxy group for the hydrogen at the 5-position. It is a metabolite of Brassica napus, a human urine metabolite, an antibacterial agent, a marine xenobiotic metabolite, a carcinogen, and a rodent metabolite. It belongs to the indole-3-acetic acid class of compounds and is also an aromatic ether. 5-Methoxyindole-3-IAA has also been reported in Daphnia pulex and Solanum lycopersicum, with corresponding data available.
5-Methoxyindole-3-acetic acid is a naturally occurring metabolite found in pineal tissue. It is also known as 5-methoxy-3-indoleacetic acid. The compound is derived from melatonin. It is a chemical reagent used in the analysis of the physiological properties of auxins. It is available in high purity (≥98%) for research applications. Its role as a melatonin metabolite makes it a valuable tool for studying pineal function and circadian rhythms. |
| Molecular Formula |
C₁₁H₁₁NO₃
|
|---|---|
| Molecular Weight |
205.21
|
| Exact Mass |
205.074
|
| CAS # |
3471-31-6
|
| PubChem CID |
18986
|
| Appearance |
Yellow to brown solid powder
|
| Boiling Point |
445.9ºC at 760 mmHg
|
| Melting Point |
145-148 °C (dec.)(lit.)
|
| Flash Point |
223.5ºC
|
| LogP |
1.803
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
3
|
| Heavy Atom Count |
15
|
| Complexity |
244
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
COCNDHOPIHDTHK-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C11H11NO3/c1-15-8-2-3-10-9(5-8)7(6-12-10)4-11(13)14/h2-3,5-6,12H,4H2,1H3,(H,13,14)
|
| Chemical Name |
2-(5-methoxy-1H-indol-3-yl)acetic acid
|
| Synonyms |
5Methoxyindole3acetic acid; 5 Methoxyindole 3 acetic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~100 mg/mL (~487.31 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (12.18 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (12.18 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.8731 mL | 24.3653 mL | 48.7306 mL | |
| 5 mM | 0.9746 mL | 4.8731 mL | 9.7461 mL | |
| 10 mM | 0.4873 mL | 2.4365 mL | 4.8731 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
